U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950385) titled 'Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis' on April 10.
Brief Summary: The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compare eRapa to Placebo. The questions to be answered by this trial are:
* Does taking eRapa help to slow down the progression of the disease in patients with FAP?
* Is eRapa a safe treatment for patients diagnosed with FAP?
* What is the effect of eRapa on the number of polyps found in GI tract of patients diagnosed with FAP?
* How does tr...